<DOC>
	<DOCNO>NCT01367912</DOCNO>
	<brief_summary>To test hypothesis add estradiol ( E2 ) progesterone supplementation later luteal phase vitro fertilization ( IVF ) /intracytoplasmic sperm injection ( ICSI ) cycle , rather early luteal phase , improve clinical pregnancy rate ( PRs ) .</brief_summary>
	<brief_title>Timing Estrogen Support During Luteal Phase Vitro Fertilization ( IVF ) /Intracytoplasmic Sperm Injection ( ICSI ) Cycle</brief_title>
	<detailed_description>Several study report elevated E2 may detrimental effect endometrial receptivity embryo . This conflict start point study . The investigator think luteal decrease E2 level could prevent add estradiol receptivity window open , instead add earlier luteal phase could result defective embryo implantation .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>All patient long GnRH agonist protocol control ovarian hyperstimulation see IVF clinic February November 2008 , E2 level day hCG administration &gt; 2500 pg/dl Presence azoospermia require testicular sperm extraction procedure endometriosis great stage II unilateral oophorectomy , polycystic ovarian syndrome ( PCOS ) secondary infertility age great 40 yr basal follicle stimulate hormone ( FSH ) level high 12 mIU/ml exclusion criterion</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Luteal phase support</keyword>
	<keyword>estradiol supplementation</keyword>
	<keyword>IVF/ICSI</keyword>
	<keyword>clinical pregnancy rate</keyword>
</DOC>